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Abstract
Background: Classically, progesterone has been thought to act only through the well-known
genomic pathway involving hormone binding to nuclear receptors and subsequent modulation of
gene expression. However, there is increasing evidence for rapid, non-genomic effects of
progesterone in a variety of mammalian tissues and it is possible that a membrane PR (mPR) is
causing these events. We recently isolated and characterized an ovine mPR referred to as mPR-
alpha, distinct from the nuclear PR. Based on predicted structural analysis, the ovine mPR-alpha
possesses seven transmembrane domains typical of G protein-coupled receptors. Despite the
homology to other reported mPRs, information pertaining to the steroid binding characteristics of
the ovine mPR-alpha was lacking. Additionally, the ovine mPR-alpha transcript has been identified
in the hypothalamus, pituitary, uterus, ovary and corpus luteum, yet changes in expression of the
ovine mPR-alpha in these tissues were not known. Consequently, the purpose of this work was to
determine the steroid binding characteristics of the ovine mPR-alpha and to investigate possible
changes in expression of the ovine mPR-alpha in reproductive tissues throughout the estrous cycle.
Methods: Binding studies were performed using crude membrane fractions from CHO cells
expressing the mPR-alpha. Using quantitative Real-time PCR we determined the expression pattern
of mRNA for the ovine mPR-alpha during the ovine estrous cycle in tissues known to express the
mPR-alpha. Jugular blood samples were also collected and analyzed for serum concentrations of P4
to ensure ewes were at the appropriate stage of their cycle.
Results:  Only progesterone, 20alpha-hydroxyprogesterone and 17alpha-hydroxyprogesterone
were able to displace binding of 3H-P4 (P < 0.001) to membrane fractions from CHO cells
expressing ovine mPR-alpha. The average B-max and Kd values for three separate experiments
were 624 +/- 119 fmol/micro gram protein and 122 +/- 50 nM, respectively. Significant changes in
expression of mRNA for the mPR-alpha during the estrous cycle were noted in the corpus luteum
and uterus.
Conclusion: The mPR-alpha specifically binds progestins and its expression was correlated to
progesterone secretion during the ovine estrous cycle. Results from the present studies suggest
that mPR-alpha may have an important physiological role during the ovine estrous cycle.
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Background
Progesterone (P4) is a steroid hormone produced prima-
rily by the ovary with the amount of P4 secreted depend-
ing on the level of gonadotropin stimulation and the
physiological status of the ovary. Granulosa cells, theca/
stromal cells and luteal cells all secrete P4 albeit at differ-
ent levels [1-3]. Progesterone has many biological effects
in a variety of tissues, and as such considerable research
has focused on the mechanisms through which P4 medi-
ates its actions. Many physiological effects of P4 are medi-
ated through gene regulation by the nuclear P4 receptors
(nPR) that function as ligand-dependent transcription
factors. More recently, P4 also has been shown to evoke
rapid stimulatory effects through a variety of signal trans-
duction molecules and pathways (reviewed in [4]) and it
is thought that these non-genomic effects are the result of
P4 binding to a membrane PR (mPR). A unique mPR with
seven hydrophobic amino acid domains indicative of a
prototypical G protein-coupled receptor (GPCR) was
recently cloned from the sheep [5] and shares significant
homology to other reported mPRs [6-9]. Despite the
homology of the ovine mPRα with mPRα from other spe-
cies, information pertaining to the steroid binding charac-
teristics of the ovine mPRα is lacking. An essential
criterion to verify the putative ovine mPRα as a true recep-
tor is to identify the ligand(s) that binds to the ovine
mPRα and to determine the binding kinetics of this puta-
tive receptor. The first mPR isolated was from seatrout and
these researchers utilized soluble recombinant protein
produced in BL21 E. coli cells to determine the steroid
binding characteristics [9]. Saturable binding of P4 was
obtained with the recombinant protein and competition
studies revealed binding was highly specific for progestins
[9]. Similar results were obtained with recombinant
human mPRα, mouse mPRβ and human mPRγ produced
in an E. coli expression system [8].
Use of recombinant protein for binding studies provides
researchers with a fairly straightforward method to evalu-
ate interaction between ligand and receptor. However,
limitations exist with this system as the protein synthe-
sized may lack the normal tertiary structure and may lack
post-translational modifications that would be present in
situ. As such, the binding characteristics of the reported
mPRs may be different in vivo than those obtained using
a soluble form of the receptor. A paper investigating the
regulation of membrane progestin receptors in the rat cor-
pus luteum (CL) provides a better understanding of the
binding characteristics of the mammalian mPRs [6]. Bind-
ing of [3H]-progesterone was evaluated in subcellular frac-
tions of corpora lutea obtained from rats on d 14 of
pregnancy. It was found that various progestins competed
for binding of the radiolabeled P4 [6] and since these
binding studies were performed with luteal membranes,
the results may provide a better representation of the
binding kinetics in vivo. These researchers also reported
the presence of five genes expressed in the rat CL previ-
ously postulated to encode for putative membrane recep-
tors for P4 [6]. Thus, it is difficult to verify which, or if all,
of these proteins actually bind P4.
Coupled with determining the binding kinetics of the
ovine mPRα, deciphering possible changes in expression
of this receptor in vivo is also critical to help define the
physiological role of the ovine mPRα. Changes in the
level of expression of the mammalian mPRα have been
demonstrated in the rat CL during pregnancy [6], human
endometrium [10], human cervix and myometrium [11],
and in human myometrial cells following exposure to P4
or estradiol [7]. Currently, the only tissues known to
express the ovine mPRα are the hypothalamus, pituitary,
uterus, ovary and CL [5]. Whether the level of expression
of the ovine mPRα in these tissues changes throughout
the estrous cycle is not known. Given that the ovine mPRα
transcript is found predominately in reproductive tissues,
elucidating possible changes in levels of mPRα expression
throughout the ovine estrous cycle is paramount.
Experiments were conducted to test the hypothesis that P4
is the true ligand for the ovine mPRα and that levels of
transcript for the ovine mPRα in reproductive tissues fluc-
tuate depending on the stage of the estrous cycle. Conse-
quently, in this study we determined the steroid binding
characteristics of the ovine mPRα, by performing binding
studies using solubilized crude membrane fractions from
Chinese hamster ovarian (CHO) cells expressing the
sheep mPRα. By using a mammalian cell line, the post-
translational modifications of the receptor should be
unaltered, yet the tertiary structure may be affected by sol-
ubilization. Changes in levels of expression of the ovine
mPRα were also examined in the hypothalamus, pituitary,
uterus, non-luteal components of the ovary, and CL
throughout the estrous cycle.
Methods
Saturation binding experiments and competition curves
A stable cell line which expresses the ovine mPRα was
generated for the binding studies involving ligand satura-
tion and competition curves. CHO cells were transfected
with a vector (pcDNA3.1+) encoding ovine mPRα using
the Polyfect procedure (QIAGEN, Valencia, California,
USA) according to manufacturer's instructions. Twenty
four hours after transfection, the medium was changed,
and G418 (Mediatech, Inc., Herndon, Virginia, USA) was
added to a final concentration of 400 μg/mL. After 2
weeks of selection in G418, the cells were trypsinized and
serially diluted in complete medium plus G418, plated
into wells of a 96-well tissue culture plate, and incubated
until single colonies became visible. Each well that con-
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time colonies were trypsinized and transferred to a single
well of a 24-well tissue culture plate. Once these colonies
reached confluence, individual colonies were trypsinized
and each colony was cultured in a single well of a 6-well
tissue culture plate. The same procedure was performed
again, but colonies were seeded onto a 90 mm tissue cul-
ture dish. Expression of the ovine mPRα was determined
in each colony by RT-PCR for the ovine mPRα using pro-
cedures described by Ashley and colleagues [5]. Mem-
brane fractions from the stable CHO cell line expressing
ovine mPRα were incubated with increasing concentra-
tions of 3H-P4 for the saturation binding experiments. The
binding studies were performed as described below in the
"Receptor Binding Assays" section, except that the incuba-
tion time was increased to 4 h at 4°C based on the time
course experiments. Data from the saturation experiments
were analyzed by nonlinear regression analysis using
GraphPad Prism (Version 4a, from GraphPad Software,
Inc.). Binding of 3H-P4 was also measured in the presence
of increasing concentrations of P4, 20α-hydroxyproges-
terone or 17α-hydroxyprogesterone to determine the half-
maximal inhibitory concentration (IC50) of these pro-
gestins. The IC50 of the progestins was obtained by nonlin-
ear fitting of inhibition curves using GraphPad Prism
(Version 4a, from GraphPad Software, Inc.).
Receptor Binding Assays
A crude membrane fraction was prepared from CHO cells
and CHO cells transfected with cDNA for ovine mPRα fol-
lowing procedures as described [12] with slight modifica-
tions. CHO cells transfected with a vector (pcDNA3.1+)
encoding ovine mPRα using the Polyfect procedure (QIA-
GEN, Valencia, California, USA) were cultured in DMEM,
supplemented with 10% FBS, non-essential amino acids
(8.9 mg/L L-Alanine, 15 mg/L L-Asparagine, 13.3 mg/L L-
Aspartic acid, 14.7 mg/L L-Glutamic acid, 7.5 mg/L Gly-
cine, 11.5 mg/L L-Proline and 10.5 mg/L L-Serine) and
penicillin-streptomycin (100 I.U. penicillin and 100 μg/
mL streptomycin). At 48 h post-transfection, transfected
and non-transfected CHO cells were washed with cold
PBS and removed from tissue culture plates using a cell
scraper and cold PBS, and concentrated by centrifugation.
Cells were washed again with cold PBS, counted using a
hemacytometer and lysed in homogenization buffer (100
mM KCl, 5 mM MgCl2, 50 mM Tris-HCl, 1 mM EGTA,
plus protease inhibitors; pH 7.2) with a QIAshredder
(QIAGEN, Valencia, CA) per manufacture's instructions.
Supernatants were collected and spun at 100,000 × g at
4°C for 1 h. Supernatants were removed and pellets con-
taining the membrane fractions were resuspended in cold
sample buffer (10 mM Tris-HCl, 250 mM sucrose, 1 mM
EGTA, plus protease inhibitors; pH 7.2). An aliquot of the
membrane fractions from transfected and nontransfected
cells was kept separate and protein concentration was
determined using the Coomassie Plus Protein Assay Kit
(Pierce; Rockford, Illinois, USA). Duplicate aliquots of
membrane fractions from CHO cells transfected with
mPRα and from nontransfected CHO cells were incu-
bated at 4°C for 1 h in 0.3 mL TEDG buffer (10 mM Tris-
HCl, 1.5 mM EDTA, 1 mM Dithiothieitol, 10% Glycerol;
pH 7.6) containing 4 nM 3H-progesterone (3H-P4) and
250 μM digitonin. Bound and free ligands were separated
by the addition of 0.8 mL ice cold dextran-coated charcoal
(0.3 g defined charcoal and 0.03 g Dextran [Sigma, St
Louis, MO] in 100 mL of TEDG buffer) and incubation on
ice for 10 min. After centrifugation at 1100 × g for 15 min
at 4°C, 0.9 mL supernatants were carefully removed,
mixed with 5 mL of ScintiSafe scintillation cocktail (Fisher
Chemical, Fair Lawn, New Jersey, USA) and radioactivity
was quantified in a Beckman scintillation spectrometer.
Non-specific binding was measured in duplicate in the
presence of a 1000-fold excess of nonradioactive P4.
Other binding experiments were performed with increas-
ing concentration of protein and increasing incubation
time. Additional controls included tubes without cell
membrane fractions but with 3H-P4 and digitonin. To test
the specificity of binding for the ovine mPRα, binding of
3H-P4 was measured in the presence of 1000-fold excess
of several other nonradioactive steroids. Statistical analy-
sis of the results from the competition binding studies
were performed using the Newman-Keuls Multiple Com-
parison Test in Prism (Version 4a, from GraphPad Soft-
ware, Inc.) and significance was taken as a value of P <
0.05.
Relative expression of mRNA for ovine mPRα throughout 
the estrous cycle
All procedures involving animals were approved by the
Colorado State University Animal Care and Use Commit-
tee. Ewes were exposed to a vasectomized ram to deter-
mine the onset of estrus. On day 13–14 of the cycle, ewes
were administered dinoprost tromethamine (Lutalyse)
(7.5 mg I.M.) two times, 4 h apart for estrus synchroniza-
tion. Before the first dose of Lutalyse, jugular blood sam-
ples were taken from each ewe for analysis of serum
concentrations of P4. Jugular blood samples were also
taken daily from each ewe until time of euthanasia. Blood
was allowed to clot for 1 h at room temperature and
serum was collected by centrifugation. Serum was stored
at -20°C until analyzed for concentrations of P4. Follow-
ing Lutalyse treatment, ewes were observed continually in
the presence of a vasectomized ram until estrus was
detected, at which time ewes were subsequently assigned
to various groups depending on when estrus was first
observed. Groups consisted of 3 h and 24 h post onset of
estrus and days 4, 10, and 15 of the estrous cycle. At the
appropriate time of the cycle, tissues (hypothalamus,
pituitary, whole uterine sections, corpora lutea, and ova-
ries minus corpora lutea) were excised from sheep follow-
ing euthanasia with sodium pentobarbitol andReproductive Biology and Endocrinology 2009, 7:42 http://www.rbej.com/content/7/1/42
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exsanguination, and snap frozen in liquid nitrogen for
subsequent isolation of RNA. Total RNA was extracted
using the RNeasy Midi Kit (QIAGEN, Valencia, California,
USA) according to manufacturer's instructions. To ensure
RNA samples were not contaminated with genomic DNA,
each sample was subjected to RNase-Free DNase treat-
ment (QIAGEN, Valencia, CA). Concentration of RNA
was determined by spectrophotometry, and integrity of
RNA verified by gel electrophoresis in 1% agarose in the
presence of ethidium bromide followed by visualization
under UV light. A set concentration of RNA (1 μg) was
reverse-transcribed into cDNA using the iScript cDNA
Synthesis Kit employing the reverse transcriptase RNAse
H+ (Bio-Rad Laboratories, Hercules, CA) per manufac-
turer's instructions. The RT products were diluted to a
final volume of 100 μL. Quantitative PCR was performed
using a Bio-Rad iCycler iQ Real-Time PCR Detection Sys-
tem (Bio-Rad Laboratories, Hercules, CA). Real-time
quantitative PCR was performed in single wells of a 96-
well plate (Bio-Rad Laboratories, Hercules, CA) using
components of the iQ SYBR Green supermix (2×), 0.5 μM
forward and reverse specific primers, and 10 μL of the RT
product. As a negative control for all the reactions, prepa-
rations lacking RNA or reverse transcriptase were used in
place of the cDNA. The following primers were used for
PCR amplification: Ovine mPRα, TTGTGGGCACCGT-
GGACTTC and GCTAAGGCACTGAGGGAGAGG; Ovine
β-actin TCTGGCACCACACCTTCTAC and GGTCATCT-
TCTCACGGTTGG. The following PCR thermocycling pro-
gram was used: 95°C for 3 min, followed by 40 cycles
consisting of 95°C for 10 sec and 55°C for 45 sec, fol-
lowed by one cycle each of 95°C for 1 min, and 55°C for
1 min and a melt curve. Fluorescence was measured after
each cycle and displayed graphically (iCycler iQ Real-
Time Detection System Software, version 3.1; Bio-Rad).
The software determined the cycle threshold (Ct) values
for each sample. Data were normalized by subtracting the
Ct value of actin from the Ct value of mPRα for each ewe
on each day tested. Sample RNAs were assayed from three
to five independent biological replicates. Statistical analy-
sis was performed on the normalized data using the New-
man-Keuls Multiple Comparison Test in Prism (Version
4a, from GraphPad Software, Inc.) and significance was
taken as a value of P < 0.05. When a significant difference
(P < 0.05) was noted, the RNA levels were reported as a
fold change in the text, using the "Delta-delta method" for
comparing relative expression results in real-time PCR
[13]. Data are shown as the mean values (actin Ct/mPRα
Ct) ± S.E.
Radioimmunoassay for serum progesterone
The concentration of P4 in serum from the ewes was
quantified by a double antibody radioimmunoassay [14].
Triplicate standard curves were included in each assay and
samples were analyzed in duplicate at 200 μL sample/
tube.
Results
As shown in Figure 1A, binding of 3H-P4 increased with
increasing amounts of membrane fractions from mPRα-
CHO cells. In contrast little binding was observed in the
membrane fractions from CHO cells. Likewise, binding of
3H-P4 increased with incubation time reaching a plateau
at approximately 4 h at 4°C (Figure 1B). A representative
saturation curve of 3H-P4 binding to membrane fractions
A) Binding of 3H-progesterone (cpm) was measured in  increasing amounts of crude membranes from CHO cells and  CHO cells expressing mPRα Figure 1
A) Binding of 3H-progesterone (cpm) was measured 
in increasing amounts of crude membranes from 
CHO cells and CHO cells expressing mPRα. Displace-
ment of 3H-progesterone was measured in the presence of 
1000-fold excess nonradioactive progesterone. Values are a 
representation of three individual experiments. B) Binding of 
3H-Progesterone in crude membrane fractions from CHO 
cells expressing the ovine mPRα at various times of incuba-
tion. Displacement of 3H-progesterone was measured in the 
presence of 1000-fold excess nonradioactive progesterone. 
Values are means ± S.E. (n = 4).
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from mPRα-CHO cells is shown (Figure 2). The average
Bmax and Kd values of three separate experiments were 624
± 119 fmol/μg protein and 122 ± 50 nM, respectively.
A variety of steroids were tested (1000-fold excess) for
their abilities to displace binding of 3H-P4 to crude mem-
brane fractions of mPRα transfected CHO cells. Only
excess P4, 20α-hydroxyprogesterone and 17α-hydroxy-
progesterone were able to significantly (P < 0.001) dis-
place binding of radiolabeled P4. Estradiol, testosterone,
cortisol and the P4 antagonist RU486 failed to inhibit
binding of 3H-P4 to crude membranes from CHO cells
expressing mPRα (Figure 3).
Based on the competition binding studies, additional
experiments were performed to more clearly evaluate the
abilities of P4, 20α-hydroxyprogesterone and 17α-
hydroxyprogesterone to displace binding of radiolabeled
P4 to crude membranes from mPRα-CHO cells (Figure 4).
Low levels of P4 (IC50 = 174 nM) competed for binding of
the tracer in a dose-dependent manner (Figure 4),
whereas higher concentrations of 20α-hydroxyprogester-
one (IC50 = 298 nM) or 17α-hydroxyprogesterone (IC50 =
735 nM) were required to reduce binding by 50% (Figure
4).
To determine if there were possible changes in expression
of mPRα throughout the ovine estrous cycle, ewes were
Representative saturation curve in the presence of increasing  concentrations of 3H-progesterone Figure 2
Representative saturation curve in the presence of 
increasing concentrations of 3H-progesterone. The 
Bmax and Kd values of 3H-progesterone binding were 624 
fmol/μg protein and 122 nM, respectively. The inset shows 
Scatchard analysis of the same data.
Displacement of 3H-progesterone from crude membranes of  CHO cells expressing mPRα in the presence of vehicle or  1000-fold excess of nonradioactive steroids Figure 3
Displacement of 3H-progesterone from crude mem-
branes of CHO cells expressing mPRα in the pres-
ence of vehicle or 1000-fold excess of nonradioactive 
steroids. Steroids included progesterone (P4), 17α-hydrox-
yprogesterone (17-OH-P4), 20α-hydroxyprogesterone (20-
OH-P4), estradiol, testosterone, cortisol, or RU486. Values 
are means ± S.E. (n = 3). *P < 0.001, compared to vehicle 
control.
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Specificity of progestin binding sites for ovine mPRα Figure 4
Specificity of progestin binding sites for ovine mPRα. 
Binding of 3H-progesterone was measured in the absence or 
in the presence of increasing concentrations of nonradioac-
tive progestins. Progestins evaluated included progesterone 
(P4), 20α-hydroxyprogesterone (20-OH-P4) and 17α-
hydroxyprogesterone (17-OH-P4). Each point represents the 
average ± S.D. of progestin binding expressed as a percent-
age of maximum 3H-progesterone binding.Reproductive Biology and Endocrinology 2009, 7:42 http://www.rbej.com/content/7/1/42
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euthanized and tissues were collected at 3 h and 24 h post
onset of estrus and then at days 4, 10, and 15 of the
estrous cycle. Jugular blood samples were also collected
and analyzed for serum concentrations of P4 to ensure
ewes were at the appropriate stage of their cycle. As shown
in Figure 5 all of the ewes appeared to be synchronized
and displayed low serum concentrations of P4 at the
beginning of their cycle; levels then increased to maximal
concentrations on d 8 and then began to decline at the
end of the cycle. No apparent differences were observed
for mean relative expression of mRNA for mPRα in
hypothalamus (Figure 6A), the non-luteal component of
the ovary (Figure 6B), or pituitary (Figure 6C) during the
estrous cycle. In contrast, in the CL, the highest expression
of mRNA for mPRα was observed on d 10 and was 3.9, 4.5
and 2.5 fold greater (P < 0.01) than expression on d 4 or
at 3 h and 24 h post estrus, respectively (Figure 6D). Addi-
tionally, the expression of mPRα in the CL was 2.2 and 2.6
fold greater (P < 0.05) on d 15 compared to 3 h and 24 h
post estrus, respectively (Figure 6D). The highest expres-
sion of mRNA for mPRα in the uterus was on d 4 when it
was 3.7 fold higher (P < 0.01) than mRNA at 3 h post
onset of estrus (Figure 6E).
Discussion
Our studies demonstrate binding of 3H-P4 in membrane
fractions from cells expressing the ovine mPRα. Currently,
limited binding data for the mammalian mPRα homologs
exists. Only P4, 20α-hydroxyprogesterone and 17α-
hydroxyprogesterone significantly (P < 0.001) displaced
binding of 3H-P4 to membrane fractions from CHO cells
expressing ovine mPRα. Similar to the ovine mPRα, the
seatrout mPRα also exhibits specific binding for P4, 20β-
hydroxyprogesterone and 17α-hydroxyprogesterone [9].
Additionally, MDA-231 cells expressing the human mPRα
also display specific binding for P4 [15]. Other steroids
tested in the current study did not compete for 3H-P4
binding further supporting progestins as the true ligand
for the ovine mPRα. It is important to note the membrane
fractions used in the present study are comprised of the
plasma membrane as well as membranes from other cel-
lular organelles. Specific binding sites for P4 have been
detected in microsomal rich fractions in a variety of mam-
malian species. Bramley and Menzies [16] reported P4
binding sites in ovine CL that are unlike classical nuclear
PRs in that they are enriched in intracellular membrane
fractions and not found in the cytosolic or nuclear frac-
tions. Also, in those studies, RU486, the nuclear PR antag-
onist did not block P4 binding to intracellular
membranes suggestive of a PR unlike the nPR [16]. Like-
wise, in the present study RU486 failed to compete for 3H-
P4 binding in membrane fractions from CHO cells
expressing ovine mPRα. Similar results have been
reported for microsomal fractions of corpora lutea from
cows [17], pigs [18], humans [19] and rat [20]. These data
Serum concentrations (ng/mL) of P4 in synchronized ewes Figure 5
Serum concentrations (ng/mL) of P4 in synchronized 
ewes. Five ewes were assigned to each time period and syn-
chronized with Lutalyse (7.5 mg I.M.) injections two times, 4 
h apart. Time periods included 3 h and 24 h post estrus and 
days 4, 10, and 15 of the estrous cycle. For clarity, serum 
concentrations of P4 are only shown from onset of estrus (d 
1) to d 15. Data are means ± S.E. (n = 5 ewes/time period).
0
0.5
1
1.5
2
2.5
3
3.5
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Days Related to Synchronized Estrous
P
4
 
(
n
g
/
m
L
) 24 h
4 d
10 d
15 d
0
0.5
1
1.5
2
2.5
3
3.5
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Days Related to Synchronized Estrous
P
4
 
(
n
g
/
m
L
) 24 h
4 d
10 d
15 d
Comparison of mean relative expression of mRNA encoding  mPRα versus mRNA encoding actin in ovine A) hypothala- mus, B) non-luteal components of the ovary, C) pituitary, D)  corpus luteum, or E) uterus throughout the estrous cycle (3  h and 24 h post estrus and days 4, 10, 15) Figure 6
Comparison of mean relative expression of mRNA 
encoding mPRα versus mRNA encoding actin in 
ovine A) hypothalamus, B) non-luteal components of 
the ovary, C) pituitary, D) corpus luteum, or E) 
uterus throughout the estrous cycle (3 h and 24 h 
post estrus and days 4, 10, 15). Values on the y-axis 
(actin Ct/mPRα Ct) represent means ± SE of a minimum of 
three sheep. Significant differences (P < 0.05) between 
groups are indicated by different letters above the bars.
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provide further support for a PR functionally distinct from
the classic nuclear PR with predominant localization in an
intracellular membrane such as the endoplasmic reticu-
lum. We previously demonstrated that the ovine mPRα is
predominantly localized in the endoplasmic reticulum
and upon ligand activation causes a release of Ca2+ from
the endoplasmic reticulum [5]. While we cannot for cer-
tain rule out that cellular localization of the receptor may
be altered in CHO cells, we have performed a plethora of
studies using mPRα fusion proteins in primary pituitary
and luteal cells and have observed the same localization
of mPRα in these cells as noted in CHO cells. This unique
localization to the endoplasmic reticulum has since been
corroborated in cells expressing the human mPRα [21].
The apparent dissociation constant of 122 nM from our
saturation experiments is well within the range of values
reported for other membrane P4-binding proteins,
including those found in bovine CL [197 nM] [17], rat
liver [170 nM] [22] porcine liver [11–286 nM] [23] and
the rat brain [160 nM] [24]. Additionally, in a paper inves-
tigating the various receptors for P4 in rat CL, which con-
tains the mPRα homolog, an apparent dissociation
constant of 162 nM was observed [6]. Although the ovine
mPRα has a relatively low affinity, given its expression in
the CL, it is plausible that luteal membrane P4-binding
sites are completely saturated because of the high intral-
uteal concentration of P4. Additionally, to date very little
data are available pertaining to the binding characteristics
of the mammalian mPR homologs. Information pre-
sented in this paper coupled with the binding studies in
membranes from rat CL [6] and MDA-MB-231 breast car-
cinoma cells transfected with cDNA encoding the human
mPRα [15] provide some of the first data describing the
binding characteristics of the mammalian mPRs.
In terms of binding kinetics, the ovine mPRα shares
greater similarities with the rat mPR than the human or
non-mammalian homolog. The Kd reported in membrane
fractions from rat CL is 162 nM which is similar to the 122
nM Kd for the ovine mPRα. It is noteworthy to mention
that the rat CL expresses 5 genes which encode for putative
membrane P4 receptors [6]. Thus, direct comparison of
our data with that from the rat is difficult because it is not
known how many of the proteins in the rat CL are
expressed and may bind P4. The current ovine mPRα and
the recent human mPRα binding data [15] are the first
studies to demonstrate and characterize progestin binding
in cells expressing the mPRα homolog alone. The human
mPRα displays binding kinetics that differs from the
ovine receptor as Thomas and colleagues demonstrated
that the human mPRα has a Kd of 4.2 nM. The reasons for
the differences in the Kd are not known but may be due to
structural differences among species or to experimental
protocols. Nevertheless, the relatively low affinity for the
ovine mPRα plus the data demonstrating the lack of
RU486 binding provide further evidence that the mam-
malian mPRs appear to function in a manner distinct
from the nPRs.
As the ovine mPRα transcript is predominately found in
reproductive tissues [5], we decided to investigate possible
changes of mPRα expression throughout the ovine estrous
cycle in these tissues. Using real-time quantitative RT-
PCR, no significant changes were observed across the
estrous cycle in amounts of mRNA for mPRα in the
hypothalamus, non-luteal components of the ovary, or
pituitary. Despite no significant changes across time in the
hypothalamus, relative expression of mPRα did appear to
be higher in the hypothalamus compared to other tissues
tested. In the ovine CL, mRNA for the mPRα increased
from estrus throughout the cycle and was significantly (P
< 0.01) higher on d 10 compared to 3 h and 24 h post
onset of estrus or d 4 of the cycle (Figure 6D). The expres-
sion of mPRα in the CL remained elevated on d 15 and
was significantly (P < 0.05) higher compared to 3 h and
24 h post onset of estrus (Figure 6D). It is important to
note, that CL samples taken from sheep at 3 h and 24 h
post onset of estrus in actuality represent the corpus albi-
cans. As noted, relative expression of the mPRα was signif-
icantly (P < 0.05) lower in the corpus albicans samples
compared to d 10 and d 15 samples, providing support for
a functional role for mPRα in the CL. Comparing serum
concentrations of P4 (Figure 5) to the expression of mPRα
in the CL (Figure 6D), it is evident that expression of
mPRα closely mimics serum concentrations of P4 suggest-
ing that the ovine mPRα may be regulated by P4 and that
the mPRα may play a central role in the regulation of CL
function. The only other data available regarding mPRα
expression in the CL is from the rat [6]. These researchers
however, measured changes in mRNA throughout preg-
nancy in the rat CL and observed that mPRα expression
increased with advancing gestation and then dramatically
decreased prior to parturition. Thus, similar to our obser-
vations expression of mPRα in the rat CL also mimicked
serum concentrations of P4 [6] further suggesting that
mPRα plays a key role in CL function.
As with changes in levels of expression of mPRα in the CL,
very little data exist pertaining to changes in expression of
the mammalian mPRα in other tissues. Karteris et al. [7]
demonstrated that P4 and estradiol significantly induced
expression of mRNA for human mPRα in human myome-
trial cells. Additionally, expression of mRNA for the
human mPRα was reported throughout the myometrium
with peak levels observed in spontaneously laboring
women [11]. However, this observation is in direct con-
trast to Fernandes et al. [10] who described a 50% reduc-
tion in mRNA for mPRα in lower segment myometrium
from spontaneously laboring women. In the currentReproductive Biology and Endocrinology 2009, 7:42 http://www.rbej.com/content/7/1/42
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study, uterine mRNA on d 4 of the estrous cycle contained
the highest levels of expression for the ovine mPRα. The
expression of the mPRα was significantly (P  < 0.01)
higher on d 4 of the estrous cycle compared to 3 h post
onset of estrus with an approximate 4 fold increase in
mRNA (Figure 6E). Although not significantly different,
the expression of mPRα appears to decrease sequentially
from d 4 to days 10 and 15 (Figure 6E). Though estradiol
was not assayed in our serum samples, the difference in
expression of mPRα noted between 3 h post onset of
estrus and d 4 may be due to changes in the ratio of circu-
lating P4 and estradiol. During the estrous cycle it is gen-
erally thought that early in the cycle concentrations of
estradiol in blood are higher compared to P4 until the CL
increases production and secretion of P4. As concentra-
tions of P4 increase in circulation throughout the luteal
phase of the cycle, estradiol levels decrease. As such, at 3 h
post onset of estrus the ratio of estradiol to P4 in circula-
tion should be higher than on d 4 of the cycle when estra-
diol is low and serum concentrations of P4 are increasing.
Whether the differences in expression of the ovine mPRα
throughout the estrous cycle are due to changes in the
serum concentrations of P4 and estradiol is currently not
known and future studies are designed to address this
issue.
In addition to the alpha homolog of the mPR, two other
mPRs termed beta and gamma also exist in mammals. The
current study detailed expression and binding characteris-
tics of mPRα as this was the first mPR we isolated from
sheep [5]. However, we have recently demonstrated
expression of mRNA for both mPRβ and mPRγ in the CL
and endometrium of sheep (unpublished data) and
future studies are aimed at investigating the functions of
all mPRs in these tissues. Further, we have also isolated
the progesterone membrane receptor component 1
(PGMRC1) from ovine CL (unpublished data) which was
originally purified from porcine tissue [23,25]. The
PGMRC1 is expressed in rat CL during pregnancy [6] and
its potential role in mediating antiapoptotic actions of P4
in spontaneously immortalized granulosa cells has been
investigated in detail by Peluso and co-workers [26]. The
precise functions of PGMRC1 and the other mPRs in the
sheep are currently not known, but studies are on-going to
decipher the physiological functions of these receptors.
Conclusion
In summary, the binding characteristics of the ovine
mPRα and the first characterization of expression of the
ovine mPRα throughout the estrous cycle in the hypotha-
lamus, pituitary, uterus, non-luteal components of the
ovary, and CL are presented. Past studies have reported
binding of P4 within microsomal fractions from corpora
lutea of a variety of mammalian species, [18,19,27-29],
however, the protein interacting with P4 was not eluci-
dated. The ovine mPRα is the first mammalian protein
identified that both localizes to the endoplasmic reticu-
lum [5] and binds P4. The studies presented herein
describe the in vivo profile for changes in expression of
mPRα in the hypothalamus, pituitary, non-luteal compo-
nents of the ovary, uterus, and CL during the ovine estrous
cycle. Characterizing fluctuations in expression may aid in
helping to define the physiological functions of mPRα.
While further studies are required to characterize the
actions of mPRα, the expression of this atypical P4 recep-
tor provides an exciting venue for research into mediation
of non-genomic effects of P4. Recently, mPRs have been
reported to activate Gi [15]. If this is true for the ovine
mPRα, it could be involved in mediating a rapid negative
effect of P4 on GnRH/LH secretion via interaction with
receptors in the hypothalamus and/or anterior pituitary
gland. The existence of a unique form of P4 receptor that
contains seven transmembrane domains and resides in
the endoplasmic reticulum is exciting and fuels enthusi-
asm for further research into the mode of action for this
receptor. This novel method of signaling at the endoplas-
mic reticulum and the existence of multiple ligands for the
ovine mPRα adds to the intricacy of signaling in cells and
provides a mechanistically unique method for initiating
actions of progestins that may alter classical dogma
regarding the mechanisms by which steroid hormones
act.
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